KYMR Kymera Therapeutics, Inc.
KYMR Kymera Therapeutics, Inc.
Healthcare · Biotechnology
Desk view
Market read
Scan convergence 2 scans as of 2026-10-23 2 neutral converging
POC $84.86 · VWAP $91.80 · +20.7% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
3 watchlists
KYMR Price Structure
Loading timeframes…
Peers
Every watchlist KYMR belongs to, members best 30-day change first — KYMR highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@ibb
@biotech-scan
@monster-discoveries
Decision history
1 scored call · newest first · projection
How to read this: Positive 30-day excess supports an enter call. For pass, avoid, sell, or exit calls, a positive number means the name kept rising after the call.
Reported the quarter ending 2026-06-30: revenue $65M, diluted EPS -$0.62, net income -$61M (SEC filing). Across the print the stock moved +1.9% (close before → first close after).
full note →Against street estimates
How KYMR's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
Recent news
Headlines about KYMR from the desk's news pull — links go to the publisher. Not a desk read: the market read above is the desk's own.
pulled 10 days ago · Oct 13
- Kymera Therapeutics Stock Price | KYMR Stock Quote, News, and History | Markets Insider
- Kymera Therapeutics Stock Price | KYMR Stock Quote, News, and History | Markets Insider
- Kymera Therapeutics (Nasdaq:KYMR) - Análisis de acciones - Simply Wall St
- Kymera Therapeutics Inc Stock Price Today | NASDAQ: KYMR Live - Investing.com
- Press Releases | Kymera Therapeutics, Inc.
“On or before” marks an article that arrived without a publish date — the date shown is when the desk pulled it, so the article is at least that old.
KYMR research tape
96 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.
Desk commentary
Authored analysis and challenge notes tied to KYMR.
Vertical: Biotech Capital Cycle — the theme is confirmed; the question is now entries